Navigation Links
Cancer Diagnostics Universe Discussed in Comprehensive VPG Research Study Published at

London, UK (PRWEB) August 06, 2014

The market for cancer diagnostics is on the verge of exploding, as the research workers approach key technology advances relating to tumour diagnosis and treatment, discover novel tumour-specific antigens, and also get to the heart of the mystery of the genetic basis of this insidious disease. Over the next five years, the global cancer diagnostics marketplace promises to be a very dynamic and rapidly expanding sphere. Expected advancements in technology will create multiple opportunities for determining genetic susceptibility, identifying specific tumours, and investigating the human body's biological response to cancer therapy and treatment. Furthermore, the upsurge in the ageing human population is anticipated to compound the soaring demand for malignancy assays and the fast-paced market expansion from pole to pole.

Comprehensive study “2014 Market Segmentation Analysis of the Global Cancer Diagnostics Industry: Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Hospitals, Commercial Labs, POC Locations” prepared by Venture Planning Group (VPG) is now available at

Report Details:

Title: 2014 Market Segmentation Analysis of the Global Cancer Diagnostics Industry: Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Hospitals, Commercial Labs, POC Locations
Published: July, 2014
Pages: 1200
Price: US$ 34,500.00

The research report provides a strategic analysis of key business opportunities in the cancer diagnostics market globally with a focus on the 7 key countries (France, Germany, Italy, Japan, Spain, the UK, and the USA) in the forthcoming years. The report examines trends in the regions covered; reviews current and emerging assays; analyses potential applications of innovative diagnostic technologies; covers sales and market shares of leading suppliers of cancer diagnostic products (by test and country); presents sales and test volume forecasts of leading tumor markers by market segment and country; profiles the dominant players along with potential entrants into the market. A variety of business expansion strategies for suppliers are identified in the research study as well.

Report Scope:

  •         Overview of the global tumour diagnostics market, including 5-year test volume and sales projections by country; market segmentation analysis; the estimated number of laboratories performing respective testing (by country); tumour statistics, etiology and latest developments region-wise.
  •         Up-close look at the opportunities arising including appropriate strategic recommendations.
  •         Thorough study of more than 200 cancer diagnostic tests, current and emerging.
  •     Suppliers’ shares and market shares (by test and country); 5-year test volume and sales forecast data for key tumour markers (by country and market segment).
  •     Comprehensive assessment of instrumentation for cancer testing.
  •     Assessment of modern technologies (including complementing/ competing ones) and their potential applications for cancer diagnostic testing; extensive listings of organisations developing novel tumour diagnostic tests and detection technologies.    
  •         Strategic evaluations of the top suppliers and start-ups that develop new cancer diagnostic products and technologies.

More comprehensive and new market research reports by the publisher can be found at VPG page.

Read the full story at

Source: PRWeb
Copyright©2014 Vocus, Inc.
All rights reserved

Related medicine news :

1. Study Suggests Vaccine May Help Kids With Brain Cancer
2. New Stool Test Might Aid in Early Detection of Colon Cancer
3. Study reveals how cancer drug causes diabetic-like state
4. How a cancer drug leads to diabetes
5. You Survived Cancer: Now Pay Attention to Your Overall Health
6. New drug prevents spread of human prostate cancer cells
7. Eliminating the good cholesterol receptor may fight breast cancer
8. Taller, Heavier Women May Face Higher Ovarian Cancer Risk
9. Experimental Chemo Combo for Colon Cancer Disappoints
10. Veggies Like Broccoli, Cabbage May Help Fight Breast Cancer: Study
11. Targeted therapeutics for colon cancer to be presented at AACR meeting
Post Your Comments:
(Date:10/12/2017)... WAUSAU, Wis. (PRWEB) , ... October 12, 2017 ... ... formulated standard products to meet the demand of today’s consumer and regulatory authorities ... team of probiotic experts and tested to meet the highest standard. , ...
(Date:10/12/2017)... ... ... The American College of Medical Informatics (ACMI) will present the 2017 Morris F. ... AMIA’s Annual Symposium in Washington, D.C. AMIA’s Annual Symposium is taking place ... the field of medical informatics, this prestigious award is presented to an individual whose ...
(Date:10/12/2017)... ... October 12, 2017 , ... Information ... we intend to develop to enable prevention of a major side effect of ... loss, especially in pediatric patients. For cisplatin, hearing loss is FDA listed on-label ...
(Date:10/12/2017)... ... October 12, 2017 , ... HMP , a leader in healthcare ... Folio Magazine Eddie Digital Award for ‘Best B-to-B Healthcare Website.’ Winners were announced during ... , The annual award competition recognizes editorial and design excellence across a range of ...
(Date:10/12/2017)... ... 12, 2017 , ... On Saturday, October 21, the Health & Wellness Center ... to raise money for the American Heart Association Heart Walk. Teams of up to ... together to keep their treadmills moving for 5 hours. Treadmills will start at 7:00 ...
Breaking Medicine News(10 mins):
(Date:10/7/2017)... --  Provista, a proven leader in the supply ... power, today announced a new resource area on ... is the online home for case studies, articles on ... releases, slideshows and events. ... at their fingertips, viewers can also watch short videos ...
(Date:10/4/2017)... , Oct. 4, 2017 ... single-use, self-contained, illuminating medical devices, today announced regulatory ... Health Surveillance Agency (or Agência Nacional de Vigilância ... first single-use, cordless surgical retractor with integrated LED ... optimal access, illumination and exposure of a tissue ...
(Date:10/2/2017)... announces the European launch of their new low volume, high throughput ... Cambridge, U.K on October 4th. The new ... unprecedented speed and sensitivity while using far less sample volume through ... ... ...
Breaking Medicine Technology: